相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies
Maria Casal-Dominguez et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Dermatomyositis autoantibodies: how can we maximize utility?
Luqman Mushila Hodgkinson et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
Urmi Khanna et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Dermatomyositis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
Adam Reich et al.
PRZEGLAD DERMATOLOGICZNY (2021)
Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence
Maria Casal-Dominguez et al.
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY (2021)
A North American Cohort of Anti-SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases
Jemima Albayda et al.
ACR OPEN RHEUMATOLOGY (2021)
Dermatomyositis: Clinical features and pathogenesis
Madeline E. DeWane et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Dermatomyositis: An Update on Diagnosis and Treatment
Gabriela A. Cobos et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis
Nobuaki Ikeda et al.
JOURNAL OF DERMATOLOGY (2020)
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen
Julie De Vooght et al.
RHEUMATOLOGY (2020)
The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants
Dario Didona et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2020)
TIF1 Proteins in Genome Stability and Cancer
Roisin M. McAvera et al.
CANCERS (2020)
Risk Factors and Cancer Screening in Myositis
Siamak Moghadam-Kia et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
Z. Betteridge et al.
JOURNAL OF AUTOIMMUNITY (2019)
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
Alexander Oldroyd et al.
RHEUMATOLOGY (2019)
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis
Marion Best et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Dermatomyositis: Current concepts
Ivan Bogdanov et al.
CLINICS IN DERMATOLOGY (2018)
Antinuclear antibodies and cancer: A literature review
Alexandru Vlagea et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Autoantibodies in myositis
Neil J. McHugh et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies
Paige W. Wolstencroft et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
Minoru Satoh et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis
Angela Ceribelli et al.
CLINICAL RHEUMATOLOGY (2017)
Risk of Malignancy in Dermatomyositis and Polymyositis: A Systematic Review and Meta-Analysis
Judy K. Qiang et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
Sarah L. Tansley et al.
JOURNAL OF AUTOIMMUNITY (2017)
HIGH-RESOLUTION MANOMETRY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY: ELEVATED PREVALENCE OF ESOPHAGEAL INVOLVEMENT AND DIFFERENCES ACCORDING TO AUTOANTIBODY STATUS AND CLINICAL SUBSET
Maria Casal-Dominguez et al.
MUSCLE & NERVE (2017)
Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients
Anna Rogers et al.
ARTHRITIS CARE & RESEARCH (2017)
Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients
Jemima Albayda et al.
ARTHRITIS CARE & RESEARCH (2017)
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
Z. Betteridge et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies
Jeannette M. Olazagasti et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2015)
Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association?
A. M. Molina-Ruiz et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2015)
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
David F. Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy
Vidya Limaye et al.
MUSCLE & NERVE (2015)
High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis
Yoshinao Muro et al.
RHEUMATOLOGY (2015)
Cancer-Induced Autoimmunity in the Rheumatic Diseases
Ami A. Shah et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
Manabu Fujimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
David F. Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2013)
Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
Yasuhito Hamaguchi et al.
PLOS ONE (2013)
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
Yuki Ichimura et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
Manabu Fujimoto et al.
ARTHRITIS AND RHEUMATISM (2012)
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort
Elena Tarricone et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Morbidity and Mortality in Adult Polymyositis and Dermatomyositis
Isabelle Marie
CURRENT RHEUMATOLOGY REPORTS (2012)
Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update
Paula Morris et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis
Z. E. Betteridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein
Graciela Espada et al.
JOURNAL OF RHEUMATOLOGY (2009)
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
Hector Chinoy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis
Zoe Betteridge et al.
ARTHRITIS AND RHEUMATISM (2007)
Dynamic regulation of p53 subnuclear localization and senescence by MORC3
Keiko Takahashi et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji et al.
RHEUMATOLOGY (2007)
Malignancies and soluble tumor antigens in rheumatic diseases
Eva Szekanecz et al.
AUTOIMMUNITY REVIEWS (2006)
A novel autoantibody to a 155-kd protein is associated with dermatomyositis
Ira N. Targoff et al.
ARTHRITIS AND RHEUMATISM (2006)
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen
GJD Hengstman et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study
R Buchbinder et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
